Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.41 |
| ▸ | CNR2 | P34972 | 3/20 | 0.41 |
| ▸ | ESR1 | P03372 | 5/20 | 0.39 |
| ▸ | SERPINE1 | P05121 | 3/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ACP1 | P24666 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18776012 | 0.89 | ACP1 (0.42) | ESR1SERPINE1GAATDP1ACP1 | |
| SCHEMBL25476189 | 0.89 | CNR1 (0.46) | CNR1CNR2ESR1SERPINE1CA12 | |
| SCHEMBL15615318 | 0.79 | CA12 (0.56) | CNR1CNR2ESR1CA12CA1 | |
| SCHEMBL18776009 | 0.79 | L3MBTL1 (0.50) | ESR1GAATDP1CHRM2CHRM4 | |
| SCHEMBL25476176 | 0.78 | L3MBTL1 (0.52) | TDP1 | |
| SCHEMBL8088168 | 0.77 | CNR2 (0.63) | CNR1CNR2ESR1 | |
| SCHEMBL18775849 | 0.76 | GAA (0.54) | ESR1GAATDP1CHRM1KDR | |
| SCHEMBL18775851 | 0.76 | GAA (0.53) | ESR1CA12CA1CA2CA7 | |
| SCHEMBL25476221 | 0.75 | SMN1; SMN2 (0.39) | ESR1TDP1 | |
| SCHEMBL20656245 | 0.75 | ALDH1A1 (0.45) | CNR1CNR2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10968175-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-04-06 | — | — | US | disclosed |
| US-20190113843-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10968175-B2 | Resist composition and patterning process | HNRNPU, BRWD1, BICRA | CNR1 448/4885CNR2 955/4885ESR1 1474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.